Systemic aspergillosis as cause of myocardial infarction.

Abstract:

:Systemic aspergillosis is encountered with increasing prevalence in immunocompromised patients undergoing chemotherapy. The current communication describes the clinical and postmortem findings in three leukemic patients who developed myocardial infarction secondary to Aspergillus embolization of the coronary arteries. They were all immunosuppressed owing to previous chemotherapy and had been treated for suspected fungal infection with amphotericin B (0.6 mg/kg) for at least 1 week prior to this episode. It is postulated that the infection was spread through the blood since in all three cases the descending branch of the left coronary artery was occluded. Heart involvement resulting from fungal infection should be suspected when chest symptoms of unknown origin occur in this patient population.

journal_name

Cancer

journal_title

Cancer

authors

Andersson BS,Luna MA,McCredie KB

doi

10.1002/1097-0142(19861101)58:9<2146::aid-cncr2820

subject

Has Abstract

pub_date

1986-11-01 00:00:00

pages

2146-50

issue

9

eissn

0008-543X

issn

1097-0142

journal_volume

58

pub_type

杂志文章

相关文献

CANCER文献大全
  • The dysfunctional federally mandated proficiency test in cytopathology: a statistical analysis.

    abstract::Proficiency testing in cytopathology and in other disciplines should be based on firm statistical and scientific foundations, because test theory in general is a heavily statistical subject. Statistical considerations have demonstrated that the design of "short" proficiency tests in cytopathology, including the curren...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23154

    authors: Nagy GK,Naryshkin S

    更新日期:2007-12-25 00:00:00

  • Pathologic classification of prostate carcinoma: the impact of margin status.

    abstract:BACKGROUND:A proposed pathologic (pTNM) classification system for prostate carcinoma was analyzed for its impact on survival outcome in the prostate specific antigen (PSA) era. The impact of margin status on the survival outcome of patients with otherwise organ-confined disease (i.e., without extraprostatic extension o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980301)82:5<902::aid-cnc

    authors: Blute ML,Bostwick DG,Seay TM,Martin SK,Slezak JM,Bergstralh EJ,Zincke H

    更新日期:1998-03-01 00:00:00

  • Angioimmunoblastic lymphadenopathy progressing to immunoblastic lymphoma with prominent gastric involvement.

    abstract::Two unusual cases of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), with progression to immunoblastic lymphoma (IL) and prominent gastric involvement are presented, and detailed immunohistologic studies described. In one case, Bence Jones proteinuria of the kappa type was observed during the course of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821115)50:10<2089::aid-cncr282

    authors: Bauer TW,Mendelsohn G,Humphrey RL,Mann RB

    更新日期:1982-11-15 00:00:00

  • Serum immunoglobulin levels in patients with breast cancer.

    abstract::Serum immunoglobulin levels IgA, IgG, and IgM have been estimated in 92 patients with breast cancer and 50 control patients, 40 of whom had benign disease of the breast. In patients with breast cancer, IgA was significantly raised at all stages and IgG was significantly reduced, but the two abnormalities were not nece...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197507)36:1<221::aid-cncr2820360

    authors: Roberts MM,Bathgate EM,Stevenson A

    更新日期:1975-07-01 00:00:00

  • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.

    abstract:BACKGROUND:Five-year survival rates after resection of liver metastases from colorectal carcinoma are close to 25%. Recurrences occur in two-thirds of the patients after surgery. Selection of patients likely to benefit from surgery remains controversial and subjective. METHODS:Data from 1568 patients with resected liv...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Nordlinger B,Guiguet M,Vaillant JC,Balladur P,Boudjema K,Bachellier P,Jaeck D

    更新日期:1996-04-01 00:00:00

  • A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.

    abstract:BACKGROUND:Sunitinib has replaced interferon (IFN) as a first-line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. METHODS:Data were collected on all patients i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24051

    authors: Heng DY,Chi KN,Murray N,Jin T,Garcia JA,Bukowski RM,Rini BI,Kollmannsberger C

    更新日期:2009-02-15 00:00:00

  • Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration.

    abstract:BACKGROUND:This survey documents the strategies used by pain control physicians in the selection of opioid drugs and routes of administration in the management of inpatients referred to a cancer pain service. METHODS:The following approaches were prospectively evaluated during the treatment of 100 consecutive inpatien...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19951001)76:7<1283::aid-cncr2820

    authors: Cherny NJ,Chang V,Frager G,Ingham JM,Tiseo PJ,Popp B,Portenoy RK,Foley KM

    更新日期:1995-10-01 00:00:00

  • Cure rate estimation and long-term prognosis of uterine cervix carcinoma.

    abstract::This paper reports the prognosis results of a retrospective study of over 2000 cases of uterine cervix carcinoma totally treated at Institut Gustave-Roussy from 1950 to 1963. From the study of their long-term survival, an overall cure rate was estimated at 49% seven years after the start of primary treatment. A study ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810101)47:1<203::aid-cncr28204

    authors: Pejovic MH,Wolff JP,Kramar A,Goldfarb E

    更新日期:1981-01-01 00:00:00

  • Weight gain with breast cancer adjuvant treatment.

    abstract::Available information suggests that individuals with breast cancer gain weight during adjuvant treatment and that this weight gain may be associated with poor prognosis. Exploration of the factors which affect weight gain may aid in developing weight control interventions for these patients. To determine the factors w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910401)67:7<1954::aid-cncr2820

    authors: Levine EG,Raczynski JM,Carpenter JT

    更新日期:1991-04-01 00:00:00

  • Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.

    abstract:BACKGROUND:Transitional cell carcinoma (TCC) is rare in the female genital tract. Although it is most common in the ovary, small series of cases in the cervix have been reported, with isolated cases described in the fallopian tube, adnexa uteri, and endometrium. METHODS:Eight cases of primary TCC involving the endomet...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Lininger RA,Ashfaq R,Albores-Saavedra J,Tavassoli FA

    更新日期:1997-05-15 00:00:00

  • Chemotherapy for advanced or recurrent gynecologic cancer.

    abstract::Studies of chemotherapy in advanced or recurrent gynecologic cancer have focussed on ovarian, cervical, and endometrial carcinoma. For celomic epithelial carcinomas of the ovary, a large number of cytotoxic agents have been shown to be active. Dramatic improvement in frequency of response with lesser improvement in su...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19901015)60:8+<2104::aid-cncr282

    authors: Thigpen T,Vance R,Lambuth B,Balducci L,Khansur T,Blessing J,McGehee R

    更新日期:1987-10-15 00:00:00

  • The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women.

    abstract::Cytopathologists recognize that certain Pap smear findings are suspicious for endometrial pathology in menopausal women. To study their prognostic importance in the directed cervical smear, six parameters were used to evaluate smears for evidence of an endometrial lesion: the presence of (1) histiocytes, (2) multinucl...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851101)56:9<2256::aid-cncr2820

    authors: Zucker PK,Kasdon EJ,Feldstein ML

    更新日期:1985-11-01 00:00:00

  • Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases.

    abstract::Peripheral blood changes preceding therapy-related leukemia were studied in 105 patients who had received cytotoxic therapy, 53 for Hodgkin's disease and 52 for other cancers. Preleukemic anomalies were observed in 74.3% of the cases, appearing after a mean interval of 68.7 months after diagnosis of the initial cancer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860801)58:3<630::aid-cncr28205

    authors: De Gramont A,Louvet C,Krulik M,Smadja N,Donadio D,Laporte JP,Brissaud P,Smith M,Delâge JM,Drolet Y

    更新日期:1986-08-01 00:00:00

  • Immunohistochemical localization of adenosine deaminase in human benign extrathymic lymphoid tissues and B-cell lymphomas.

    abstract::Immunomorphologic methods were utilized to localize adenosine deaminase (ADA) in extrathymic benign lymphoid tissues and B-cell lymphomas. In reactive lymph nodes, tonsils and appendix, germinal centers displayed strong ADA-positive nuclear staining in small cleaved lymphocytes and weak nuclear and/or cytoplasmic stai...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840101)53:1<70::aid-cncr282053

    authors: Chechik BE,Schrader WP,Perets A,Fernandes B

    更新日期:1984-01-01 00:00:00

  • Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.

    abstract:BACKGROUND:National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN)-designated cancer centers (CCs) offer patients state-of-the-art treatment, but their impact on multiple myeloma (MM) patient outcomes has not been evaluated. METHODS:Adult MM patients diagnosed between 1973 and 2011 were identified...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29771

    authors: Ailawadhi S,Advani P,Yang D,Ghosh R,Swaika A,Roy V,Foran J,Colon-Otero G,Chanan-Khan A

    更新日期:2016-02-15 00:00:00

  • Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part I: Studies of cancer in families.

    abstract::Hereditary cancer represents approximately 5-10% of the total cancer burden and may account for 60,000 to 120,000 new cancer occurrences this year in the United States. New developments in molecular genetics and the cloning of cancer-prone genes have intensely fueled interest in dealing with hereditary forms of cancer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19991201)86:11+<2449::aid-

    authors: Lynch HT,Watson P,Shaw TG,Lynch JF,Harty AE,Franklin BA,Kapler CR,Tinley ST,Liu B

    更新日期:1999-12-01 00:00:00

  • A standard dose of radiation for "microscopic disease" is not appropriate.

    abstract::Elective irradiation of sites of potential occult tumor spread is often part of a patient's radiation therapy program. The required radiation dose (D) depends on the probability that occult disease exists (P(occ)), the number of sites at risk (A), the number of tumor clonogens present (Ni), their radiation sensitivity...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19901215)66:12<2498::aid-cncr282

    authors: Marks LB

    更新日期:1990-12-15 00:00:00

  • Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.

    abstract:BACKGROUND:Scarce data exist concerning the outcome of very elderly patients with head and neck squamous cell carcinoma (HNSCC). METHODS:The clinical files of 316 patients aged > or = 80 years with HNSCC who were included in the authors' hospital database between 1987 and 2006 were reviewed retrospectively. RESULTS:A...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23931

    authors: Italiano A,Ortholan C,Dassonville O,Poissonnet G,Thariat J,Benezery K,Vallicioni J,Peyrade F,Marcy PY,Bensadoun RJ

    更新日期:2008-12-01 00:00:00

  • Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.

    abstract:BACKGROUND:Nilotinib is a potent, second-generation inhibitor of BCR-ABL1 tyrosine kinase and has been approved as frontline and salvage therapy for patients with chronic-phase chronic myeloid leukemia (CP-CML). METHODS:In this single-institution, phase 2 study, 122 patients with newly diagnosed CP-CML received niloti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32623

    authors: Masarova L,Cortes JE,Patel KP,O'Brien S,Nogueras-Gonzalez GM,Konopleva M,Verstovsek S,Garcia-Manero G,Ferrajoli A,Kadia TM,Ravandi-Kashani F,Borthakur G,DellaSala S,Estrov Z,Jabbour EJ,Kantarjian HM

    更新日期:2020-04-01 00:00:00

  • High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.

    abstract:BACKGROUND:To identify the factors that contribute to poorer colon carcinoma survival rates for African Americans compared with Caucasians, the authors evaluated survival differences based on the histologic grade (differentiation) of the tumor. METHODS:All 169 African Americans and 229 randomly selected non-Hispanic C...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21021

    authors: Alexander D,Jhala N,Chatla C,Steinhauer J,Funkhouser E,Coffey CS,Grizzle WE,Manne U

    更新日期:2005-05-15 00:00:00

  • An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.

    abstract:BACKGROUND:Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated. METHODS:Ambulatory patients with advanced urothelial carcinoma were treated with the nonclassic antifol trimetrexate at ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/1097-0142(19940201)73:3<688::aid-cncr28207

    authors: Witte RS,Elson P,Khandakar J,Trump DL

    更新日期:1994-02-01 00:00:00

  • Hemorrhagic cystitis with MOPP therapy.

    abstract::After 12 cycles of MOPP therapy for Hodgkin's Disease, an adolescent black male developed hemorrhagic cystitis, which clinically and histologically was similar to that induced by cyclophosphamide. At that time he had a normal platelet count and had never been irradiated below the diaphram. The markedly contracted blad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197804)41:4<1261::aid-cncr282041

    authors: Royal JE,Seeler RA

    更新日期:1978-04-01 00:00:00

  • Ethnic patterns of childhood cancer in Hawaii between 1960 and 1984.

    abstract::Cases of childhood cancer (less than 15 years of age at diagnosis), diagnosed between 1960 and 1984, were obtained from the Hawaii Tumor Registry, a population-based Surveillance, Epidemiology, and End Results (SEER) participant covering the entire State of Hawaii. During the 25 years of data collection, cancer was di...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891015)64:8<1758::aid-cncr2820

    authors: Goodman MT,Yoshizawa CN,Kolonel LN

    更新日期:1989-10-15 00:00:00

  • A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.

    abstract:BACKGROUND:Because angiogenesis may play a role in the pathogenesis of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS), and thalidomide (Th) has shown significant anti-angiogenic activity, this study was designed to investigate the potential role of Th in the treatment of patients with AML and...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.11180

    authors: Cortes J,Kantarjian H,Albitar M,Thomas D,Faderl S,Koller C,Garcia-Manero G,Giles F,Andreeff M,O'Brien S,Keating M,Estey E

    更新日期:2003-03-01 00:00:00

  • A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen.

    abstract::Thirty-one patients with advanced, biopsy-proven squamous cell carcinoma (SCC) of the head and neck were treated with intraarterial chemotherapy (IAC) and subsequent radical surgery. Cisplatin at 25 mg/d (4 hours of infusion) and bleomycin at 15 mg/d (20 hours of infusion) were administered for 10 consecutive days. Ra...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890901)64:5<994::aid-cncr28206

    authors: Sulfaro S,Frustaci S,Volpe R,Barzan L,Comoretto R,Monfardini S,Carbone A

    更新日期:1989-09-01 00:00:00

  • Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.

    abstract:BACKGROUND:Previous studies have indicated that the incidence and mortality rates for multiple myeloma have increased in the United States. The authors reported on the incidence of multiple myeloma in Olmsted County, Minnesota, between 1991 and 2001 and on trends in multiple myeloma incidence over the last 56 years. M...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20652

    authors: Kyle RA,Therneau TM,Rajkumar SV,Larson DR,Plevak MF,Melton LJ 3rd

    更新日期:2004-12-01 00:00:00

  • Disparities in access to care at high-volume institutions for uro-oncologic procedures.

    abstract:BACKGROUND:Socioeconomic status represents an established barrier to health care access. Age, sex, and race may also play a role. The authors examined whether these affect the access to high-volume hospitals for uro-oncologic procedures in the United States. METHODS:Within the Nationwide Inpatient Sample (NIS), the au...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27440

    authors: Trinh QD,Sun M,Sammon J,Bianchi M,Sukumar S,Ghani KR,Jeong W,Dabaja A,Shariat SF,Perrotte P,Agarwal PK,Rogers CG,Peabody JO,Menon M,Karakiewicz PI

    更新日期:2012-09-15 00:00:00

  • High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

    abstract:BACKGROUND:In this report, the authors describe their collective experience with melphalan-based autotransplants since the inception of their program at the University of Arkansas for Medical Sciences in 1989. METHODS:The authors evaluated the clinical outcomes of 3077 successive patients with multiple myeloma (MM) wh...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23327

    authors: Pineda-Roman M,Barlogie B,Anaissie E,Zangari M,Bolejack V,van Rhee F,Tricot G,Crowley J

    更新日期:2008-04-15 00:00:00

  • Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

    abstract:BACKGROUND:The carboplatin-based chemotherapeutic regimen M-CAVI (methotrexate, carboplatin, and vinblastine) is active against bladder carcinoma and can be administered to patients who are ineligible to receive cisplatin or doxorubicin. The authors designed a randomized study to evaluate whether M-CAVI offers a therap...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0142(19971115)80:10<1966::aid-c

    authors: Bellmunt J,Ribas A,Eres N,Albanell J,Almanza C,Bermejo B,Solé LA,Baselga J

    更新日期:1997-11-15 00:00:00

  • Present and future projects of the International Breast Cancer Study Group.

    abstract::The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of tim...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940801)74:3+<1139::aid-cncr282

    authors: Goldhirsch A,Gelber RD,Castiglione M,Price KN,Rudenstam CM,Lindtner J,Collins J,Senn HJ,Brunner KW,Galligioni E

    更新日期:1994-08-01 00:00:00